DNA Test for Health vs. Ancestry: What's the Difference
Ancestry tests, health and trait panels, and whole genome sequencing read different amounts of your DNA and answer different questions entirely.
Someone spits in a tube expecting health answers and gets a pie chart of Scottish and Nigerian percentages instead. It happens constantly. The category "DNA test" covers three genuinely different products: ancestry-only tests, health and trait panels, and whole genome sequencing. They don't read the same amount of DNA, they don't answer the same questions, and mixing them up is the single most common reason people end up disappointed with a kit they bought for the wrong reason.
Here's the short version. Ancestry tests compare your DNA to reference populations to estimate where your ancestors likely came from. Health and trait panels scan a curated list of specific genetic markers tied to conditions, drug responses, or physical traits. Whole genome sequencing reads essentially all of your DNA, not a preselected slice of it. Each does one job well. None of them does all three jobs equally well, and knowing which one you're holding matters before you act on anything it tells you.
What ancestry-only tests actually do
Ancestry tests work by comparing chunks of your DNA against reference panels built from people with known, documented ancestry. The output is a probability estimate: this percentage of your genome looks statistically similar to this reference population, that percentage to another. It's pattern-matching against a database, not a readout of who you are.
This is genuinely useful for genealogy and for finding relatives. It is not a health tool, and it was never built to be one. The genetic markers ancestry panels prioritize are chosen because they vary predictably across populations, not because they cause or predict disease.
There's also a subtler problem worth sitting with. A 2020 randomized controlled trial published in PLOS ONE, led by sociologist Wendy Roth, tested whether receiving ancestry test results changes how people think about race. The study's own framing captures the tension: "social scientists argue that genetic ancestry tests may promote an essentialist view of race as fixed and determining innate abilities, others suggest it" could do the opposite (PLOS ONE). The science here is unsettled. What isn't unsettled: ancestry percentages describe population history, not biology you can act on medically.
And the biology itself argues against reading too much into any of it. The Human Genome Project's completion in 2003 "confirmed humans are 99.9% identical at the DNA level and there is no genetic basis for race," according to a 2021 systematic review in Evolution, Medicine, and Public Health (PMC). Ancestry results sit on top of the 0.1% of variation. Interesting. Not medical.
What health and trait panels do differently
Health and trait DNA tests use the same underlying lab technology as ancestry kits, a genotyping chip, but they're programmed to check a specific, predetermined list of locations in your genome. Instead of scanning broadly, the chip looks at maybe half a million to a million specific spots known to be associated with particular traits: eye color, caffeine sensitivity, certain drug-metabolism genes, a handful of well-studied disease-risk variants.
The upside is speed and cost. The catch is coverage. If a variant you care about isn't one of the spots the chip was built to check, the test simply doesn't see it. The result doesn't come back negative. The question simply never got asked. This distinction gets lost in marketing copy constantly, and it's the one thing worth remembering before you buy a kit expecting comprehensive answers.
Health panels are also where genetic mutations become directly relevant, so it's worth being precise about what that word means. A genetic mutation is, per the Cleveland Clinic, "a change to your DNA sequence by removing, adding or replacing pieces of your DNA" that happens during cell division, and mutations "could lead to genetic conditions like cancer, or they could help humans better adapt to their environment over time" (Cleveland Clinic). Most mutations a consumer panel flags aren't destiny. They're a risk marker, one piece of a much bigger picture that includes family history, lifestyle, and environment.
What whole genome sequencing adds
Whole genome sequencing is a different order of test. Rather than checking a curated list of known spots, it reads through essentially the entire genome, the full sequence, not a sample of it. That distinction matters because a huge amount of what researchers know about genetic risk is still being discovered. A chip built two years ago can only check for what was known two years ago. A full genome read can be reanalyzed as the science moves, because the underlying data was never limited to a preselected list in the first place.
This approach is increasingly showing up outside the direct-to-consumer market too. A 2022 review in the Journal of Personalized Medicine describes the growth of population-level genomic screening programs, including "preventative genomic sequencing for healthy individuals" and "genetic risk assessment for people who are adopted," among other applications (PMC). That's the same underlying logic driving consumer whole genome tests: read once, use the data for more than one purpose over time.
It's also not a magic diagnostic. A 2024 review in the American Journal of Human Genetics, led by Ying Wang at the Broad Institute, notes that "advancements in genomic technologies have shown remarkable promise for improving health trajectories," but the same paper is largely about closing equity gaps in whose genomes the reference science was built from in the first place (AJHG). Depth of read doesn't automatically mean depth of certainty for every population equally. That's a real limitation of the field. No single test, including this one, escapes it.
Comparing the three side by side
| Ancestry-only test | Health/trait panel | Whole genome sequencing | |
|---|---|---|---|
| What it reads | Markers chosen to vary by population | A curated list of known trait/health markers | Essentially the entire genome |
| Best for | Genealogy, finding relatives | Specific, well-studied traits and drug-response markers | Broad, reanalyzable health and trait information |
| Can be reanalyzed as science advances | No | Limited, only within the chip's fixed marker set | Yes |
| Diagnoses disease | No | No | No |
None of these, including whole genome sequencing, diagnoses a disease. All three are risk and context tools. That line shouldn't get blurred by anyone selling a kit.
Why the harms and benefits framing matters
It's worth pausing on why the distinction between "a lot of information" and "the right information" carries real weight. A 2018 paper in Personalized Medicine by Anya Prince and Benjamin Berkman at the NIH argues that "the increasing availability of genetic information is changing views about risks and benefits" in ways that older ethical frameworks weren't built to handle (PMC). More data isn't automatically more clarity. Sometimes it's more noise, or more anxiety, without a clinician to help sort which result actually matters.
There's a legal dimension too, and it's one people rarely think about before spitting in a tube. The Genetic Information Nondiscrimination Act, or GINA, gives Americans a right to access their own genetic data and some protection against its misuse. A 2019 William and Mary Law Review analysis by Barbara Evans calls the individual access right GINA created "a crucial tool to protect people's civil rights" (PMC). GINA has limits, it doesn't cover life insurance or disability insurance, but it's the backdrop against which every consumer genetic test operates in the US.
None of this is Biome-specific. Reputable DNA testing companies typically publish their own privacy policy, their own data retention terms, and their own answer to how test results are stored and secured. Read the actual policy of whatever company you're considering rather than assuming one company's practices match another's. That's true whether you're comparing ancestry kits or genome-sequencing providers.
So which one should you actually buy
If you want to know where your ancestors came from and find distant cousins, an ancestry-only test does that job and nothing more, cheaply. If you want specific, well-studied health and trait markers, a curated panel gets you there faster and for less money than a full sequence, with the tradeoff that it only ever answers the questions it was built to ask. If you want a single sample that can be reanalyzed as the science advances rather than a fixed snapshot, whole genome sequencing is the only one of the three built for that. Biome sells both a DNA test and a whole genome test, so the practical decision is really about how much of your genome you want captured once and how much room you want for that data to keep being useful later.
FAQ
Is a DNA test for health different from an ancestry test? Yes. Ancestry tests compare your DNA to reference populations to estimate geographic origin. Health and trait tests check specific markers tied to conditions, traits, or drug response. They use similar lab methods but are built to answer different questions.
Can an ancestry test tell me my disease risk? Not reliably. Ancestry tests are built to detect population-level patterns, not the specific variants used in medical risk assessment. A dedicated health panel or whole genome test is built for that purpose instead.
Does whole genome sequencing replace a doctor's genetic testing? No. Whole genome sequencing gives you a broad, reanalyzable read of your DNA, but it isn't a diagnostic tool and doesn't replace clinical genetic counseling or doctor-ordered testing for a specific medical concern.
Are DNA test results the same at every company? No. Results depend on what the specific test reads: a curated marker chip versus a full genome sequence will surface different amounts of information. Check what a company's specific product actually measures before comparing results across providers.
Is my genetic data protected by law? Partially. The Genetic Information Nondiscrimination Act (GINA) protects against genetic discrimination in employment and health insurance and gives you a right to access your own data, but it does not cover life or disability insurance. Check the specific testing company's privacy policy for how your data is stored and used.
Sources
- Cleveland Clinic: Sleep: What It Is, Why It's Important, Stages, REM & NREM (2023)
- American Journal of Human Genetics: Aspiring toward equitable benefits from genomic advances to ... (2024)
- Journal of Personalized Medicine: The Rise of Population Genomic Screening - PMC (2022)
- Personalized Medicine: Reconceptualizing harms and benefits in the genomic age (2018)
- Cleveland Clinic: What Is a Genetic Mutation? Definition & Types (2023)
- PLOS ONE: Do genetic ancestry tests increase racial essentialism ... - PMC (2020)
- Evolution, Medicine, and Public Health: Race and genetics versus 'race' in genetics - PMC - NIH (2021)
- William and Mary Law Review: THE GENETIC INFORMATION NONDISCRIMINATION ACT ... (2019)
This article is for educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease, and it should not replace guidance from a qualified healthcare provider. Genetic results describe tendencies and predispositions, not diagnoses. Always consult a licensed clinician before making decisions about your health, medications, or supplements.